Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05924971 · ClinicalTrials.gov registry record · Phase 2
Aspirin for Postpartum Patients With Preeclampsia
A Phase 2 study of Preeclampsia Postpartum, sponsored by MemorialCare Health System.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 86
- Enrollment target
- 1
- Study location
NCT05924971: Recruiting Phase 2 study of Preeclampsia Postpartum, sponsored by MemorialCare Health System.
NCT05924971 is a Phase 2 study of Preeclampsia Postpartum that is actively recruiting participants, run by MemorialCare Health System. The registered enrollment target is 86 participants, above the 63-participant average among 8 other Preeclampsia Postpartum trials with a reported enrollment target (37% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05924971, a Phase 2 study of Preeclampsia Postpartum, is actively recruiting participants, sponsored by MemorialCare Health System.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 86 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to evaluate the effect of low-dose aspirin on recovery from severe preeclampsia (a high blood pressure disorder of pregnancy) among women who have given birth. We hypothesize that taking aspirin for the first week after giving birth will enhance recovery from preeclampsia by decreasing the levels of a protein called soluble fms-like tyrosine kinase (sFlt-1), which is thought to be a main contributor to the development of preeclampsia, and speeding up return to a normal blood pressure.
Primary Outcome
This outcome will determine the absolute change in sFlt-1, an anti-angiogenic protein implicated in the pathophysiology of preeclampsia.
Conditions Studied
Interventions
- DRUG Aspirin 81Mg Ec Tab
Study Locations (1)
California
- Miller Children's and Women's Hospital, Long Beach/MemorialCare Long Beach - Long Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2023-07-26 |
| Est. Completion | 2026-12 |
| Phase | Phase 2 |
What NCT05924971 shows while recruiting
NCT05924971 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 86 participants, a relatively small participant target, above the 63-participant average among 8 other Preeclampsia Postpartum trials with a reported enrollment target (37% higher).
The record links to 1 condition, with Preeclampsia Postpartum appearing as the primary indexed condition, and to 1 intervention - of which Aspirin 81Mg Ec Tab is the first listed.
NCT05924971 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05924971 about?
NCT05924971 is a clinical study titled "Aspirin for Postpartum Patients With Preeclampsia". The purpose of this research study is to evaluate the effect of low-dose aspirin on recovery from severe preeclampsia (a high blood pressure disorder of pregnancy) among women who have given birth. We hypothesize that taking aspirin for the first week after giving birth will enhance recovery from pr...
What is the current status of trial NCT05924971?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 86 participants. The study started on 2023-07-26. Estimated completion is 2026-12.
What conditions does trial NCT05924971 study?
This clinical trial studies the following conditions: Preeclampsia Postpartum.
What interventions are being tested in trial NCT05924971?
The interventions under investigation include: Aspirin 81Mg Ec Tab (DRUG).
Who is sponsoring clinical trial NCT05924971?
This trial is sponsored by MemorialCare Health System, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05924971 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preeclampsia Postpartum
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05924971's enrollment target sits among peer trials
86 3rd of 8 higher than 6 of 8 other Preeclampsia Postpartum trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Preeclampsia Postpartum trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Postpartum Low-Dose Aspirin and Preeclampsia
RECRUITING · Phase 2
-
Sensitivity of Angiotensin II Type II Receptors in Women Following Preeclampsia
RECRUITING · Early Phase 1
-
Aspirin and Preeclampsia
RECRUITING · Phase 4
-
Vascular Effects of High-Salt After Preeclampsia
RECRUITING · Early Phase 1
-
Preeclampsia Educational Program Study (PrEPS)
ACTIVE NOT RECRUITING · NA
-
MR and Inflammation After Preeclampsia
ACTIVE NOT RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01639508 · 86 participants · Phase 2
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
- NCT03519269 · 86 participants · NA
Navio Robotic Versus Conventional Total Knee Arthroplasty
- NCT04132999 · 86 participants · NA
PAP for Children With DS and OSAS
- NCT04545957 · 86 participants · NA
Jump: MR Simulation For Radiation Therapy Master Protocol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI